Send Inquiry

Request To Call Back

250 MG Gefitinib Tablets IP

Get a Price/Quote

MOQ : 10 Boxes

250 MG Gefitinib Tablets IP Specification

Indication
Non-small cell lung cancer (NSCLC)

Dosage Form
Tablet

Salt Composition
Gefitinib 250 mg

Feature
Oral anticancer therapy, easy administration

Ingredients
Gefitinib and pharmaceutical excipients

Application
Cancer treatment (specifically NSCLC)

Physical Color/Texture
Film-coated tablet

Storage Instructions
keep at cool and dry place

Shelf Life
24-36 months (as per manufacturers packaging)

Marketed By
Natco Pharma Ltd.

Administration Route
Oral

Usage
As directed by a physician

Intended Patient Group
Adults with confirmed EGFR mutation in NSCLC

Drug Class
EGFR Tyrosine Kinase Inhibitor

Primary Packaging
Blister strips

Warning
For use only under medical supervision

Contraindication
Hypersensitivity to Gefitinib

Brand Name
Geftinat

Pack Size
30 Tablets per box

Prescription/Non Prescription
Prescription

Strength
250 mg per tablet

250 MG Gefitinib Tablets IP Trade Information

Minimum Order Quantity
10 Boxes

FOB Port
Mumbai International Airport or By sea

Payment Terms
Letter of Credit (L/C), Letter of Credit at Sight (Sight L/C), Western Union, Paypal, Cash Advance (CA), Cash Against Delivery (CAD), Telegraphic Transfer (T/T), Cash in Advance (CID)

Supply Ability
500 Boxes Per Week

Delivery Time
7 Week

Sample Available
Yes

Sample Policy
Sample costs shipping and taxes has to be paid by the buyer

Packaging Details
1 Blister Strip of 10 Tablets

Main Export Market(s)
Asia, Australia, North America, South America, Eastern Europe, Western Europe, Middle East, Central America, Africa

Main Domestic Market
Andaman and Nicobar Islands, Chandigarh, Himachal Pradesh, Uttarakhand, Daman and Diu, Dadra and Nagar Haveli, Lakshadweep, Nagaland, , South India, North India, East India, Andhra Pradesh, Assam, Arunachal Pradesh, Bihar, Delhi, Gujarat, Goa, Jammu and Kashmir, Karnataka, Kerala, Maharashtra, Mizoram, Meghalaya, Manipur, Punjab, Pondicherry, Rajasthan, Sikkim, Tamil Nadu, Telangana, Tripura, Odisha, Jharkhand, Haryana, West Bengal, Madhya Pradesh, Central India, West India, Chhattisgarh, Uttar Pradesh, All India

Certifications
ISO/GMP/c-GMP/WHOGMP/USFDA/EUP

About 250 MG Gefitinib Tablets IP

Geftinat 250 mg Tablet is an anticancer medicine which is used in the treatment of cancer of the lungs. It should only be used under the supervision of a qualified physician. This medicine is not recommended for use in patients with lung and liver diseases.

An Effective Oral Therapy for NSCLC

Geftinat 250 MG Gefitinib Tablets offer a convenient, oral option for patients with non-small cell lung cancer marked by EGFR mutations. As a targeted EGFR tyrosine kinase inhibitor, Geftinat helps manage specific types of lung cancer and makes treatment more accessible to patients, reducing the need for frequent hospital visits. Each tablet is individually packaged, ensuring dosage accuracy and ease of distribution.

Guidance on Safe and Proper Usage

Geftinat must only be taken as directed by a qualified healthcare professional. The tablets are prescribed exclusively to adults after confirming EGFR mutation status in NSCLC cases. Regular medical monitoring is essential to oversee treatment response and detect any potential side effects early. Always store the medication in a cool, dry place to maintain its efficacy throughout its shelf life.

FAQ's of 250 MG Gefitinib Tablets IP:

Q: How should Geftinat 250 MG Gefitinib Tablets be taken?

A: Geftinat tablets should be taken orally with or without food, exactly as prescribed by your physician. Do not alter the dosage or frequency without consulting your healthcare provider.

Q: What is the intended use of Geftinat 250 MG Gefitinib Tablets?

A: This medication is intended for the treatment of adults with non-small cell lung cancer (NSCLC) that has a confirmed EGFR mutation, as determined by diagnostic testing.

Q: When should I begin taking Geftinat?

A: Geftinat should only be started after proper evaluation and diagnosis by your doctor. Begin treatment as soon as your physician prescribes the tablets and provides usage instructions.

Q: Where should I store Geftinat tablets?

A: Store Geftinat in its original blister packaging, kept in a cool, dry place away from sunlight and moisture. Strictly maintain storage instructions to preserve the medication's effectiveness.

Q: What benefits does Geftinat offer in lung cancer treatment?

A: Geftinat provides effective, targeted oral therapy for EGFR mutation-positive NSCLC, allowing treatment flexibility and reducing the necessity for inpatient administration associated with other cancer therapies.

Q: Who should not take Geftinat tablets?

A: Individuals with known hypersensitivity to gefitinib or any tablet ingredients should not use Geftinat. Consult your doctor if you have any history of allergic reactions to similar drugs.

Q: Can Geftinat be used without a prescription?

A: No, Geftinat is a prescription-only medication and must be taken strictly under the supervision and guidance of a qualified healthcare professional.

Tell us about your requirement